血管内皮生长因子-angiopoietin 嵌合体具有改善治疗性血管生成的特性
Andrey Anisimov1, Denis Tvorogov, Annamari Alitalo
1Wihuri Research Institute, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), University of Helsinki, Helsinki, 00014 Finland.
Circulation
|January 30, 2013
概括
一个新的VEGF-angiopoietin-1 (VA1) 嵌合体促进了血管生成,副作用比VEGF更少. 这种强有力的分子在缺血条件下增强了血液流动和组织 perfusion,提供了一个有前途的治疗工具.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 在心血管疾病和组织缺血症中对益血管性疗法的未满足需求.
- 血管内皮生长因子 (VEGF) 的限制,由于血管漏水等副作用.
- 作为一种潜在的血管稳定因子的angiopoietin-1.
研究的目的:
- 设计和测试结合VEGF和angiopoietin-1受体结合域的化学分子.
- 为了创建一个单一的分子,结合了血管和血管稳定性质.
- 在体内评估VEGF-angiopoietin-1 (VA1) 嵌合体的治疗潜力.
主要方法:
- 构建和测试VEGF-angiopoietin-1 (VA1) 仿真蛋白.
- 对受体结合 (VEGF受体-2,Tie2) 和激活动态的分析.
- 在体内研究中,使用小鼠模型的骨肌肉缺血来评估血液流动,血管生成和蛋白质泄漏.
主要成果:
- VA1结合并激活了VEGF受体-2和Tie2. 这两个受体.
- 与VEGF相比,VA1表现出不同的受体激活动态和下游信号.
- 与VEGF相比,VA1基因传递增强了缺血肌肉中的血液流动和血管生成,减少了蛋白质泄漏和炎症.
- VA1没有诱导与VEGF相关的血管瘤样结构.
结论:
- VA1 嵌合体是一种强大的血管生成因子,具有新的 VEGF-2 受体激活机制.
- VA1促进了缺血肌肉的增强输液,降低了血管泄漏和炎症.
- VA1 是治疗心血管疾病中的组织缺血的一个有吸引力的治疗候选者.
相关概念视频
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Role of Hematopoietic Growth Factors
3.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Development of Blood Vessels
2.0K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.0K


